Dynatronics Corporation (DYNT): Price and Financial Metrics

Dynatronics Corporation (DYNT): $0.43

0.01 (+2.35%)

POWR Rating

Component Grades













DYNT Stock Summary

  • With a market capitalization of $8,067,796, DYNATRONICS CORP has a greater market value than merely 2.35% of US stocks.
  • DYNT's price/sales ratio is 0.18; that's higher than the P/S ratio of just 3.96% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, DYNATRONICS CORP is reporting a growth rate of -257.87%; that's higher than only 6.09% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to DYNATRONICS CORP are ETD, NODK, LZB, WEYS, and TAIT.
  • DYNT's SEC filings can be seen here. And to visit DYNATRONICS CORP's official web site, go to www.dynatronics.com.

DYNT Valuation Summary

  • In comparison to the median Healthcare stock, DYNT's price/earnings ratio is 106.17% lower, now standing at -1.4.
  • Over the past 243 months, DYNT's price/sales ratio has gone down 0.1.

Below are key valuation metrics over time for DYNT.

Stock Date P/S P/B P/E EV/EBIT
DYNT 2023-01-20 0.2 0.4 -1.4 -2.1
DYNT 2023-01-19 0.2 0.4 -1.4 -2.2
DYNT 2023-01-18 0.2 0.4 -1.4 -2.2
DYNT 2023-01-17 0.2 0.4 -1.4 -2.2
DYNT 2023-01-13 0.2 0.4 -1.5 -2.3
DYNT 2023-01-12 0.2 0.4 -1.5 -2.3

DYNT Growth Metrics

    Its 2 year price growth rate is now at -8.82%.
  • The 5 year revenue growth rate now stands at 85.81%.
  • Its 2 year revenue growth rate is now at -25.36%.
DYNT's revenue has moved down $3,707,858 over the prior 15 months.

The table below shows DYNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 44.0908 -3.865095 -5.701259
2022-06-30 44.33849 -4.884425 -4.726499
2022-03-31 45.38457 -3.18997 -0.230384
2021-12-31 46.52873 -4.658405 1.359578
2021-09-30 47.96678 -1.395919 2.076729
2021-06-30 47.79865 0.382963 1.209242

DYNT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DYNT has a Quality Grade of C, ranking ahead of 58.1% of graded US stocks.
  • DYNT's asset turnover comes in at 1.247 -- ranking 12th of 186 Medical Equipment stocks.
  • IRMD, ELMD, and NUVA are the stocks whose asset turnover ratios are most correlated with DYNT.

The table below shows DYNT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.247 0.270 0.109
2021-03-31 1.151 0.274 -0.133
2020-12-31 1.193 0.274 -0.178
2020-09-30 1.241 0.282 -0.145
2020-06-30 1.302 0.283 -0.118
2020-03-31 1.464 0.300 -0.046

DYNT Price Target

For more insight on analysts targets of DYNT, see our DYNT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.00 Average Broker Recommendation 1.33 (Strong Buy)

DYNT Stock Price Chart Interactive Chart >

Price chart for DYNT

DYNT Price/Volume Stats

Current price $0.43 52-week high $0.91
Prev. close $0.42 52-week low $0.30
Day low $0.42 Volume 11,900
Day high $0.43 Avg. volume 20,205
50-day MA $0.44 Dividend yield N/A
200-day MA $0.56 Market Cap 8.11M

Dynatronics Corporation (DYNT) Company Bio

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.

DYNT Latest News Stream

Event/Time News Detail
Loading, please wait...

DYNT Latest Social Stream

Loading social stream, please wait...

View Full DYNT Social Stream

Latest DYNT News From Around the Web

Below are the latest news stories about DYNATRONICS CORP that investors may wish to consider to help them evaluate DYNT as an investment opportunity.

3 Medical Instruments Stocks to Buy as Inflation Clouds Prospects

The Zacks Medical - Instruments industry is growing on rising demand for digital health. SWAV, MLAB and DYNT are set to gain the most. Yet, the ongoing inflation in the form of rising freight, raw material and labor costs is an overhang.

Yahoo | November 24, 2022

Dynatronics Corporation (DYNT) Reports Q1 Loss, Tops Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of 33.33% and 2.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 10, 2022

Dynatronics Corporation Reports First Quarter Fiscal Year 2023 Financial Results and Business Highlights

/ Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its first quarter of fiscal year 2023 ended September 30, 2022, and provided an update on recent business highlights.

Yahoo | November 10, 2022

Dynatronics to present at Investor Summit Group's Q4 Conference

Eagan, Minnesota--(Newsfile Corp. - November 8, 2022) - Dynatronics (NASDAQ: DYNT), today announced that John Krier, CEO of Dynatronics, will be attending the Q4 Investor Summit live in NYC at the Sheraton Times Square. Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. During the presentation, Mr. Krier will provide an update on recent business highlights. Attendees are encouraged to request a

Yahoo | November 8, 2022

Dynatronics Schedules Conference Call and Webcast to Report First Quarter Results for Fiscal 2023

Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its first quarter of fiscal year 2023 on Thursday, November 10, 2022 before the market opens.

Yahoo | November 1, 2022

Read More 'DYNT' Stories Here

DYNT Price Returns

1-mo 10.23%
3-mo -2.01%
6-mo -34.84%
1-year -47.78%
3-year -56.13%
5-year -84.01%
YTD 10.23%
2022 -60.99%
2021 23.46%
2020 -2.42%
2019 -69.59%
2018 -5.21%

Continue Researching DYNT

Want to see what other sources are saying about Dynatronics Corp's financials and stock price? Try the links below:

Dynatronics Corp (DYNT) Stock Price | Nasdaq
Dynatronics Corp (DYNT) Stock Quote, History and News - Yahoo Finance
Dynatronics Corp (DYNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8721 seconds.